Price T Rowe Associates Inc Bristol Myers Squibb CO Transaction History
Price T Rowe Associates Inc
- $883 Billion
- Q2 2025
A detailed history of Price T Rowe Associates Inc transactions in Bristol Myers Squibb CO stock. As of the latest transaction made, Price T Rowe Associates Inc holds 7,273,615 shares of BMY stock, worth $339 Million. This represents 0.04% of its overall portfolio holdings.
Number of Shares
7,273,615
Previous 5,789,376
25.64%
Holding current value
$339 Million
Previous $353 Million
4.64%
% of portfolio
0.04%
Previous 0.04%
Shares
19 transactions
Others Institutions Holding BMY
# of Institutions
2,670Shares Held
1.64BCall Options Held
22.4MPut Options Held
25.4M-
Vanguard Group Inc Valley Forge, PA195MShares$9.07 Billion0.15% of portfolio
-
Black Rock Inc. New York, NY159MShares$7.39 Billion0.15% of portfolio
-
Jpmorgan Chase & CO New York, NY108MShares$5.03 Billion0.52% of portfolio
-
State Street Corp Boston, MA94.7MShares$4.41 Billion0.17% of portfolio
-
Charles Schwab Investment Management Inc San Francisco, CA70.8MShares$3.3 Billion0.59% of portfolio
About BRISTOL MYERS SQUIBB CO
- Ticker BMY
- Exchange NYSE
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 2,126,160,000
- Market Cap $99B
- Description
- Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...